Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12879-020-05545-y http://scihub22266oqcxt.onion/10.1186/s12879-020-05545-y 33176693!7656198!33176693     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       BMC+Infect+Dis 2020 ; 20 (1): 824 Nephropedia Template TP {{tp|p=33176693|t=2020. First patient management of COVID-19 in Changsha, China: a case report |pdf=|usr=}}{{33176693}} gab.com Text First patient management of COVID-19 in Changsha, China: a case report JO: BMC Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33176693 #FOAvip BACKGROUND: In December 2019, the novel coronavirus disease 2019 (COVID-19) emerged in Wuhan, Hubei Province, China. It rapidly spread and many cases were identified in multiple countries, posing a global health problem. Here, we report the first patient cured of COVID-19 infection in Changsha, China, and the symptoms, diagnosis, treatment, and management of this patient are all described in this report. CASE PRESENTATION: A 57-year-old woman developed cough and fever after returning to Changsha from Wuhan on January 9, 2020. She tested positive for COVID-19 infection, a diagnosis which was supported by chest CT. The patient was treated with lopinavir and ritonavir tablets and interferon alfa-2b injection. A low dose of glucocorticoids was used for a short period to control bilateral lung immune response, and this patient avoided being crushed by cytokine storms that might have occurred. The clinical condition of this patient improved, and a COVID-19 assay conducted on January 25, 2020 generated negative results. This patient recovered and was discharged on January 30, 2020. CONCLUSIONS: Currently, there are numerous reports on COVID-19 infections focusing on the disease's epidemiological and clinical characteristics. This case describes the symptoms, diagnosis, treatment, and management of a patient cured of COVID-19 infection, which may serve as reference for future cases, while further studies are needed. Twit Text FOAVip First patient management of COVID-19 in Changsha, China: a case report ????BMC Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33176693 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33176693 #FOAvip English Wikipedia <ref>{{Cite pmid|33176693}}</ref> First patient management of COVID-19 in Changsha, China: a case report #MMPMID33176693 Zhou J; Cao Z; Wang W; Huang K; Zheng F; Xie Y; Jiang D; Zhou Z BMC Infect Dis 2020[Nov]; 20 (1): 824 PMID33176693show ga BACKGROUND: In December 2019, the novel coronavirus disease 2019 (COVID-19) emerged in Wuhan, Hubei Province, China. It rapidly spread and many cases were identified in multiple countries, posing a global health problem. Here, we report the first patient cured of COVID-19 infection in Changsha, China, and the symptoms, diagnosis, treatment, and management of this patient are all described in this report. CASE PRESENTATION: A 57-year-old woman developed cough and fever after returning to Changsha from Wuhan on January 9, 2020. She tested positive for COVID-19 infection, a diagnosis which was supported by chest CT. The patient was treated with lopinavir and ritonavir tablets and interferon alfa-2b injection. A low dose of glucocorticoids was used for a short period to control bilateral lung immune response, and this patient avoided being crushed by cytokine storms that might have occurred. The clinical condition of this patient improved, and a COVID-19 assay conducted on January 25, 2020 generated negative results. This patient recovered and was discharged on January 30, 2020. CONCLUSIONS: Currently, there are numerous reports on COVID-19 infections focusing on the disease's epidemiological and clinical characteristics. This case describes the symptoms, diagnosis, treatment, and management of a patient cured of COVID-19 infection, which may serve as reference for future cases, while further studies are needed. |Betacoronavirus/*genetics[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |China[MESH] |Coronavirus Infections/diagnosis/*drug therapy/physiopathology/virology[MESH] |Cough[MESH] |Female[MESH] |Fever[MESH] |Glucocorticoids/*therapeutic use[MESH] |HIV Protease Inhibitors/*therapeutic use[MESH] |Humans[MESH] |Interferon alpha-2/*therapeutic use[MESH] |Lopinavir/*therapeutic use[MESH] |Lung/diagnostic imaging[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Pneumonia, Viral/diagnosis/*drug therapy/physiopathology/virology[MESH] |Real-Time Polymerase Chain Reaction[MESH] |Reverse Transcriptase Polymerase Chain Reaction[MESH] |Ritonavir/*therapeutic use[MESH] |SARS-CoV-2[MESH] |Tomography, X-Ray Computed[MESH]First patient management of COVID-19 in Changsha, China: a case report(epmc).pdf DeepDyve Pubget Overpricing